Explore

Companies

Drugs

/

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Other/Premature Ejaculation

Premature Ejaculation

10

Pipeline Programs↗

9

Active Trials↗

8

Companies Involved↗

Premature Ejaculation is an early-stage landscape with 10 programs across 8 companies. 3 programs are in Phase 3.

Intelligence

Pipeline Metrics

Competitive Density

41/100

Pipeline Velocity

19/100

Mech. Concentration

100/100

Completion Rate

91/100

Attrition Rate

5/100

Pipeline

Programs by Phase

Preclinical5

Botulinum Toxin Type a

Galderma R&D

Serotonin Reuptake Inhibitor (SSRI)

Medipol University

Bont-a

Sir Run Run Shaw Hospital

Dapoxetine Hydrochloride

Johnson & Johnson

Dapoxetine on Demand

Ankara Training and Research Hospital

Phase 1

No programs

Phase 22

BP1.4979

Bioprojet

KH-001 ODT

Kadence Bio

Phase 33

Botox

AbbVie

Standard Treatment

Boehringer Ingelheim

Toronto Association

EMS

Approved

No programs

Analysis

Trial Status

55

clinical trials

Completed31 · 56%

Unknown status12 · 22%

Recruiting4 · 7%

Not yet recruiting4 · 7%

Terminated3 · 5%

Active, not recruiting1 · 2%

Clinical Trials

Trial Activity

55 trials

Transcutaneous Posterior Tibial Nerve Stimulation for Premature Ejaculation

Recruiting·BBoston Medical Group·N/A·NCT04207723·120 enrolled

Proof of Concept Study on BP1.4979 Effect on Primary Premature Ejaculation

Recruiting·BBioprojet·Phase 2·NCT07047404·60 enrolled

Effectiveness and Safety of TENS Therapy for Premature Ejaculation

Recruiting·BBoston Medical Group·Phase 3·NCT06425224·129 enrolled

Explorative Double-Blind Placebo Controlled Crossover Study to Evaluate the Potential Effects of KH-001 on Intravaginal Ejaculatory Latency Time (IELT), Patient-Reported Outcomes, and Safety in Men With Lifelong Premature Ejaculation (LPE)

Recruiting·KKadence Bio·Phase 2·NCT07434271·40 enrolled

Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation

Active, not recruiting·AAbdallah Mohamed Abdallah Mohamed Elgendy·Phase 2/3·NCT06851598·45 enrolled

Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation

Not yet recruiting·EEMS·Phase 3·NCT05052879·232 enrolled

Comparison of the Efficacy and Safety of Dapoxetine, Kegel Exercises, and Acupuncture in the Treatment of Premature Ejaculation: A Randomized, Double-Blind, Placebo-Controlled Trial

Not yet recruiting·MMedipol University·N/A·NCT07067970·250 enrolled

Hyaluronic Acid vs Botulinum Toxin Injection in Treatment of Lifelong Drug-Resistant Premature Ejaculation: Randomized Study

Not yet recruiting·—·N/A·NCT07236632·80 enrolled

Phase II Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Clinical Trial to Evaluate the Efficacy and Safety of VV913 Capsules in the Treatment of Premature Ejaculation

Not yet recruiting·VVigonvita Life Sciences·Phase 2·NCT07722780·500 enrolled

IX-01 Effect on Intravaginal Ejaculatory Latency Time (IELT), Patient Reported Outcomes and Safety in Men With Premature Ejaculation (PE)

Completed·IIxchelsis Limited·Phase 2·NCT03055806·239 enrolled

A Study of the Effectiveness and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation

Completed· Johnson & Johnson Pharmaceutical Research & Development, L.L.C. logo

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·Phase 3·NCT00229073·1,116 enrolled

A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation

Completed· Johnson & Johnson Pharmaceutical Research & Development, L.L.C. logo

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.·Phase 3·NCT00210613·199 enrolled

Exploratory Study of Pagoclone in Men With Premature Ejaculation.

Completed· Endo Pharmaceuticals logo

Endo Pharmaceuticals·Phase 2·NCT00370981·100 enrolled

Assessment Of Efficacy and Safety Of UK-390,957 In Men With Premature Ejaculation

Completed· Pfizer logo

Pfizer·Phase 2/3·NCT00219583·460 enrolled

Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature Ejaculation

Completed·SSohag University·Phase 3·NCT04085354·120 enrolled

Page 1 of 4

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)